Structure of c-Fms-IN-3
CAS No.: 885704-21-2
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
c-FMS inhibitor is a c-Fms kinase inhibitor with a potential as anti-inflammatory agent and antirheumatic agent.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 885704-21-2 |
Formula : | C23H30N6O |
M.W : | 406.52 |
SMILES Code : | O=C(C1=CC(C#N)=CN1)NC2=CC=C(N3CCN(C)CC3)C=C2N4CCC(C)CC4 |
MDL No. : | MFCD22124465 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319 |
Precautionary Statements: | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03042221 | - | Recruiting | April 30, 2019 | United States, Colorado ... More >> University of Colorado, Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Mary K Jackson 303-724-1650 mary.k.jackson@ucdenver.edu Contact: Terry NG, MD 303-724-2980 terry.ng@ucdenver.edu Principal Investigator: Terry ng, MD Less << | |
NCT02371369 | Pigmented Villonodular Synovit... More >>is Giant Cell Tumors of the Tendon Sheath Tenosynovial Giant Cell Tumor Less << | Phase 3 | Active, not recruiting | December 2018 | - |
NCT01548170 | Cancer | Phase 1 | Completed | - | Spain ... More >> Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Less << |
NCT03481842 | Endometriosis ... More >> Endometriosis Ovary Endometriosis Externa Endometriosis, Rectum Less << | Phase 1 Phase 2 | Not yet recruiting | September 30, 2018 | Switzerland ... More >> BioGene Pharmaceutical Ltd. Not yet recruiting Basel, Вâlе, Switzerland, 4057 Contact: J. Łanevska, Dr jula.edu@yahoo.com Less << |
NCT02880371 | Advanced Solid Tumors | Phase 1 Phase 2 | Recruiting | April 2020 | United States, California ... More >> UCLA Department of Medicine Recruiting Los Angeles, California, United States, 90095 Contact: Jonathan Goldman, MD 310-829-5471 jwgoldman@mednet.ucla.edu Principal Investigator: Jonathan Goldman, MD United States, Colorado University of Colorado Recruiting Aurora, Colorado, United States Contact: Matthew Skoch 720-848-0668 matthew.skoch@ucdenver.edu Contact: Michelle Carr 720-848-7135 michelle.l2.carr@ucdenver.edu Principal Investigator: Karl Lewis, M.D. United States, Florida Hematology Oncology Associates of the Treasure Coast Recruiting Port Saint Lucie, Florida, United States, 34952 Contact: Christine Gerdes, RN 772-408-5158 cgerdes@hemoncfl.com Principal Investigator: Seth Rosen, MD United States, Indiana Horizon Oncology Research, Inc. Recruiting Lafayette, Indiana, United States, 47905 Contact: Shelli Fassnacht, LPN 765-446-5111 mfassnacht@horizonbioadvance.com Principal Investigator: Wael A. Harb, MD United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Justin Gainor 617-724-4000 jgainor@partners.org Principal Investigator: Justin Gainor, MD United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Edgar de la Cruz 313-576-8387 delacruz@karmanos.org Principal Investigator: Amy Weise, D.O. United States, Minnesota Regions Hospital Recruiting Saint Paul, Minnesota, United States, 55101 Contact: Angie Martizna 651-254-1698 Angela.Martizna@ParkNicollet.com Principal Investigator: Arkadiusz Dudek, M.D. United States, Pennsylvania Penn State Hershey Cancer Institute Recruiting Hershey, Pennsylvania, United States, 17033-0850 Contact: Rebecca Hale, RN 717-531-1003 rhale2@pennstatehealth.psu.edu Principal Investigator: Diane Hershock, MD United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: ASKSarah Line 877-691-7274 asksarah@scresearch.net Principal Investigator: Melissa Johnson, MD United States, Texas Texas Oncology, P.A., Sammons Cancer Center Withdrawn Dallas, Texas, United States, 75246 UT Health San Antonio Cancer Center Recruiting San Antonio, Texas, United States, 78229 Contact: Epp Goodwin 210-450-5798 goodwine@uthscsa.edu Principal Investigator: John Sarantopolous, MD United States, Utah Utah Cancer Specialists Recruiting Salt Lake City, Utah, United States, 84106 Contact: Johnny Walker 801-281-6864 jwalker@utahcancer.com Principal Investigator: Justin Call, MD United States, Washington Northwest Medical Specialties Recruiting Tacoma, Washington, United States, 98405 Contact: CarrieAnn Brown, RN, OCN 253-396-5334 Principal Investigator: Jorge Chaves, MD Less << |
NCT03097601 | - | Active, not recruiting | December 30, 2019 | France ... More >> Centre Antoine LACASSAGNE Nice, France, 06189 Less << | |
NCT03694977 | Gastric Cancer | Phase 2 | Not yet recruiting | December 31, 2019 | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less << |
NCT01440959 | Gastrointestinal Stromal Tumor... More >>s Less << | Phase 2 | Completed | - | Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul,, Korea, Republic of, 138-736 Less << |
NCT03069469 | Advanced Malignant Neoplasm | Phase 1 | Recruiting | August 2019 | United States, Colorado ... More >> University of Colorado - Denver Recruiting Denver, Colorado, United States, 80204 Contact: Stephen Leong, MD United States, Oregon OHSU Recruiting Portland, Oregon, United States, 97239 Contact: Matthew Taylor, MD United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: Todd Bauer, MD Principal Investigator: Todd Bauer, MD Less << |
NCT01440959 | - | Completed | - | - | |
NCT02718911 | Solid Tumor | Phase 1 | Active, not recruiting | December 4, 2018 | United States, Colorado ... More >> Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Georgia Winship Cancer Center Emory University Atlanta, Georgia, United States, 30322 United States, New York New York University Medical Center New York, New York, United States, 10016 Columbia University College of Phys & Surgeons New York, New York, United States, 10032 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Belgium Universitair Ziekenhuis Antwerpen Edegem, Belgium, 2650 Universitair Ziekenhuis Gent Gent, Belgium, 9000 GZA St Augustinus Wilrijk, Belgium, 2610 Czechia Masarykuv Onkology Institute Brno, Czech Republic, Czechia, 656 53 Israel Rambam Medical Center Haifa, Israel, 3109601 Hadassah Medical Center Jerusalem, Israel, 9112001 Sheba Medical Center Ramat Gan, Israel, 5262000 Less << |
NCT03153410 | Pancreatic Cancer | Early Phase 1 | Recruiting | September 2020 | United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Ana DeJesus, MD 443-287-0411 adejesu1@jhmi.edu Less << |
NCT02777710 | Colorectal Cancer ... More >> Pancreatic Cancer Metastatic Cancer Advanced Cancer Less << | Phase 1 | Recruiting | June 2019 | France ... More >> Centre Léon Bérard Recruiting Lyon, France, 69008 Principal Investigator: Philippe CASSIER, MD Sub-Investigator: Lauriane EBERST, MD Sub-Investigator: Catherine TERRET, MD IUCT-oncopole Recruiting Toulouse, France, 31059 Principal Investigator: Carlos GOMEZ-ROCA, MD Sub-Investigator: Sarah BETRIAN-LAGARDE, MD Sub-Investigator: Ewa-Anna COTTURA, MD Sub-Investigator: Jean-Pierre DELORD, MD Sub-Investigator: Audrey RABEAU, MD Sub-Investigator: Thibaud VALENTIN, MD Less << |
NCT01316822 | Metastatic Cancer | Phase 1 | Completed | - | United States, Tennessee ... More >> Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States, 78229 Less << |
NCT02452424 | Melanoma Non-... More >>small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck Gastrointestinal Stromal Tumor (GIST) Ovarian Cancer Less << | Phase 1 Phase 2 | Completed | - | United States, Arizona ... More >> HonorHealth Research Institute Scottsdale, Arizona, United States, 85258 United States, California Marin Cancer Care Greenbrae, California, United States, 94904 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University St. Louis Siteman Cancer Center Saint Louis, Missouri, United States, 63130 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, South Carolina Medical University Health Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37212 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less << |
NCT01901666 | Chronic Myelogenous Leukemia ... More >> Short Stature Less << | Phase 4 | Unknown | December 2014 | India ... More >> Postgraduate Institute of Medical Education and Research Recruiting Chandigarh, UT, India, 160012 Contact: anil bhansali, MBBS,MD,DM 9316977995 anilbhansaliendocrine@rediffmail.com Less << |
NCT03557970 | Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << | Phase 2 | Not yet recruiting | December 30, 2023 | United States, Oregon ... More >> OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Elie Traer, MD 503-494-7999 traere@ohsu.edu Principal Investigator: Elie Traer, MD United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Not yet recruiting Dallas, Texas, United States, 75390 Contact: Robert Collins 214-648-3060 robert.collins@utsouthwestern.edu Sub-Investigator: Robert Collins Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.46mL 0.49mL 0.25mL |
12.30mL 2.46mL 1.23mL |
24.60mL 4.92mL 2.46mL |
Tags: c-Fms-IN-3 | c-FMS | Protein Tyrosine Kinase/RTK | 885704-21-2
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL